582 related articles for article (PubMed ID: 15031699)
1. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
3. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
4. [Parathyroid glands involvement in multiple endocrine neoplasia].
Târcoveanu E; Niculescu D; Cotea E; Moldovanu R; Vasilescu A; Crumpei F; Zbranca E; Zugun F; Rusu V; Ferariu D
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):482-96. PubMed ID: 21495355
[TBL] [Abstract][Full Text] [Related]
5. [Pre- and intraoperative localization of neuroendocrine tumors].
Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
7. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
8. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative cytological diagnosis of Sipple syndrome].
Bondarenko IO; Shapiro NA; Bogin IuN; Orlov VM; Karagulian RG; Berkovich SI
Klin Med (Mosk); 1995; 73(2):56-8. PubMed ID: 7609423
[No Abstract] [Full Text] [Related]
10. [Multiple endocrine neoplasia syndrome].
Shchepotin IB; Zotov AS
Vopr Onkol; 2005; 51(6):722-7. PubMed ID: 17037044
[No Abstract] [Full Text] [Related]
11. Imaging advances in the diagnosis of endocrine neoplasia.
Scott BA; Gatenby RA
Curr Opin Oncol; 1998 Jan; 10(1):37-42. PubMed ID: 9466483
[TBL] [Abstract][Full Text] [Related]
12. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
14. [Incidental diagnosis of medullary thyroid carcinoma (MTC) after performing 123I-metaiodobenzylguanidine (123I-MIBG) gammagraphy].
Gómez Fernández I; Zugasti Murillo A; Duran Barquero C; Ramos Moreno E; Alonso Farto JC; Almoguera Arias MI; Bittini Copano A; Domínguez Montero P; Pérez Vázquez JM
Rev Esp Med Nucl; 2004; 23(5):354-6. PubMed ID: 15450143
[TBL] [Abstract][Full Text] [Related]
15. [The imaging features of multiple endocrine neoplasia].
Jiang Y; Zhang T; Lu K; Cheng Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Feb; 18(1):11-4. PubMed ID: 9208580
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma: unusual presentation of a rare disease.
Hamdan A; Hirsch D; Green P; Neumann A; Drozd T; Molad Y
Isr Med Assoc J; 2002 Oct; 4(10):827-8. PubMed ID: 12389354
[No Abstract] [Full Text] [Related]
17. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
18. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
20. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
